A
$ Value
$0
Shares
6,325
Price
$0
Filed
May 27
Insider
Name
Bullock James
Title
—
CIK
0001172340
Roles
Director
Transaction Details
Transaction Date
2025-05-22
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
68,647
Footnotes
RSA Grant vests on May 22, 2026, pursuant to the terms of the Equity and Cash Incentive Plan.
Filing Info
Bullock James's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-05-22 | AORT | A | $0 |
Other Insiders at AORT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Horton Amy
VP, Chief Accounting Officer
|
— | $153K | 2026-03-03 |
|
Mackin James P
President & CEO
|
— | $2.5M | 2026-03-03 |
|
Berry Lance A
EVP, COO, CFO & Treasurer
|
— | $783K | 2026-03-03 |
|
Holloway Jean F
SVP, General Counsel
|
— | $744K | 2026-03-04 |
|
Davis John E
Chief Commercial Officer
|
— | $494K | 2026-03-03 |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
— | $275K | 2026-03-03 |